Introduction {#aur2070-sec-0003}
============

Autism spectrum disorder (ASD) is a family of neurodevelopmental disorders characterized by repetitive or stereotyped behaviors and deficits in social interactions. An estimated 11.9 in 1,000 children in the United States have ASD \[Durkin et al., [2017](#aur2070-bib-0006){ref-type="ref"}\]. The American Academy of Child and Adolescent Psychiatry recommends the use of multiple treatment modalities in ASD \[2014\]. Conventional non‐drug treatments, including behavioral interventions, speech and language therapy (SLT), and occupational therapy, are utilized across pediatric age groups and administered in diverse settings (e.g., home, school, and specialty clinics/offices) \[Nguyen, Krakowiak, Hansen, Hertz‐Picciotto, & Angkustsiri, [2016](#aur2070-bib-0014){ref-type="ref"}\]. Previous studies reporting on the pattern of care received by children with ASD either relied on a network of centers or providers \[e.g., Becerra et al., [2017](#aur2070-bib-0002){ref-type="ref"}\], utilized subsections of existing U.S. surveys \[e.g., Vohra, Madhavan, Sambamoorthi, & St Peter, [2014](#aur2070-bib-0018){ref-type="ref"}\], used claims analysis \[e.g., Candon et al., [2018](#aur2070-bib-0003){ref-type="ref"}\], or investigated certain age groups \[e.g., Zuckerman, Lindly, & Chavez, [2017](#aur2070-bib-0022){ref-type="ref"}; Payakachat, Tilford, & Kuhlthau, [2018](#aur2070-bib-0015){ref-type="ref"}\].

Prior research has raised concerns that children in more rural settings have access to fewer services \[Kelleher & Gardner, [2017](#aur2070-bib-0010){ref-type="ref"}\]; as well as that the type of healthcare coverage may dictate utilization of services, specifically that Medicaid provided for more interventions than commercial plans \[Wang, Mandell, Lawer, Cidav, & Leslie, [2013](#aur2070-bib-0020){ref-type="ref"}\]. Therefore, the goal of our study was to describe the caregiver‐reported pattern of non‐drug ASD treatment and its variation by geographic region and type of healthcare coverage across the United States in children aged 3--17 years. Our study recruited caregivers from the Simons Foundation Powering Autism Research for Knowledge (SPARK) cohort, a U.S.‐based online research cohort with individuals and families who have consented to providing information and medical samples to further autism research \[SPARK Consortium, [2018](#aur2070-bib-0017){ref-type="ref"}\].

Methods {#aur2070-sec-0004}
=======

Online surveys for non‐drug therapy and for the Autism Impact Measure (AIM; to assess frequency and impact of ASD symptoms \[Kanne et al., [2014](#aur2070-bib-0009){ref-type="ref"}; Mazurek et al., [2018](#aur2070-bib-0013){ref-type="ref"}\]) were sent to caregivers (i.e., parents and guardians/legally authorized representatives) in the SPARK cohort between September 13 and October 22, 2017. Invitations were sent in four batches, first inviting potentially eligible caregivers (i.e., have children with ASD registered in SPARK in required age range) that had most recently joined SPARK. Participants and their oldest ASD dependent aged 3--17 years (hereafter "child\[ren\] with ASD") had to have been living in the same household, with the caregiver as the main person supporting this child for at least the preceding 12 months. SPARK currently provides information in English and requires for inclusion that participants be able to read and understand English. The research protocol was approved by an institutional review board (Western IRB) and participants consented online. Upon completion of both surveys, participants received a \$20 online shop voucher via email.

The primary outcome measures were the types and intensities of non‐drug treatments in the preceding 12 months as reported by the caregiver, categorized into seven groups (child‐directed: behavioral, developmental and/or relationship‐based, SLT, occupational, psychological, and "other"; and parent/caregiver training). This categorization was similar to Salomone et al. \[[2016](#aur2070-bib-0016){ref-type="ref"}\] in order to allow comparisons, with the only difference being that we separated out psychological interventions from the "other" category. The main explanatory variables were geography of residence and healthcare coverage type. Geography was defined by a six‐level urban--rural classification scheme based on U.S. state and county (i.e., six‐level metropolitan statistical area \[MSA\] \[Ingram & Franco, [2014](#aur2070-bib-0008){ref-type="ref"}\]). For the analysis of the association between geography and outcomes, we collapsed this to two levels (i.e., two‐level MSA), nonmetropolitan and metropolitan, indicating "rural" and "urban," as per the classification scheme. Healthcare coverage types were categorized into mutually exclusive groups: those with only Medicaid ("Medicaid‐only"), those with only private insurance provided by an employer ("private insurance‐only"), one other type of coverage, more than one, and uninsured. Barriers \[adapted from Chiri & Warfield, [2012](#aur2070-bib-0004){ref-type="ref"}\], caregiver\'s role in access to and perceived benefits of non‐drug treatments, demographic characteristics of caregivers and children with ASD, and AIM scores were also analyzed.

*Statistical Methods* {#aur2070-sec-0005}
---------------------

Data were summarized descriptively. Types and intensities of non‐drug treatments were also stratified by geography, healthcare coverage type, and age group.

To model the associations between explanatory variables (geography, type of healthcare coverage) and outcomes, we identified covariates needed for adjustment using directed acyclic graphs \[Greenland, Pearl, & Robins, [1999](#aur2070-bib-0007){ref-type="ref"}, Supporting Information Figs. S1 and S2\], followed by propensity score methodology (inverse probability weighting) to create balance in the covariates, and finally applied regression modeling (logistic for treatment types; negative binomial for intensities). Populations did not sufficiently overlap to allow modeling the association between all four categories of insurance (i.e., Medicaid, private provided by employer, one type of coverage from the other categories, more than one coverage type) simultaneously, using multinomial logistic regression to derive propensity scores. We therefore present only a comparison between private via employer versus Medicaid. For further details, see Supporting Information Methods and Supporting Information Tables.

An intervention was counted as "absent" if a response of "don\'t know" was given. For present treatments, missing intensity values were set to 0.5 hr/week. These imputations were necessary \<5% of the time as the data were generally very well populated. For AIM, no total or domain scores were calculated if \>20% of items had missing responses.

We justified the sample size target of 5,000 based on the following: if 85% of children received at least one non‐drug treatment and up to 16 strata analyzed, a precision of 0.85 (95% confidence interval \[CI\]: 0.81, 0.89) could be achieved, which was considered adequate.

R version 3.3.2 was used for all analyses.

Results {#aur2070-sec-0006}
=======

Invitations were emailed to 11,514 of 19,142 potentially eligible caregivers. The non‐drug treatment survey was completed by 5,122 (44.5% of those invited), and the AIM by 5,001 (43.4%; Supporting Information Fig. S3). The study was closed online when the targeted sample size had been reached.

*Characteristics of Caregivers and Children with ASD* {#aur2070-sec-0007}
-----------------------------------------------------

The majority (92.1%) of the caregivers were mothers, with a mean age of 39.0 years and were mostly (76.5%) White/non‐Hispanic (Table [1](#aur2070-tbl-0001){ref-type="table"}). Two‐thirds had a higher education (completed college or higher) and most (81.2%) lived in metropolitan areas. The children with ASD were predominantly (80.0%) male, with a mean age of 9.1 years, and mostly (68.5%) White/non‐Hispanic. About two‐thirds had been diagnosed before age 5. Almost all had at least some insurance coverage. Of those who reported having ever had an IQ test, 44.6% scored \<100.

###### 

Characteristics of Caregivers and Their Children with ASD (*n* = 5,122)

  Characteristic                                                             Number (%)
  -------------------------------------------------------------------------- --------------
  *Caregivers*                                                               
  Age, years \[mean (*SD*)\]                                                 39.02 (7.30)
  Relation to child                                                          
  Mother                                                                     4719 (92.1)
  Father                                                                     314 (6.1)
  Legal guardian                                                             55 (1.1)
  Other                                                                      34 (0.7)
  Married/living with partner                                                4101 (80.1)
  Completed college or higher                                                3259 (63.6)
  Employment                                                                 
  Working (full or part‐time)                                                3024 (59.0)
  Full‐time homemaker                                                        1541 (30.1)
  Other                                                                      557 (10.9
  Race/ethnicity                                                             
  White/non‐Hispanic                                                         3919 (76.5)
  White/Hispanic                                                             301 (5.9)
  Non‐white/non‐Hispanic                                                     650 (12.7)
  Non‐white/Hispanic                                                         252 (4.9)
  More than one child with autism in family                                  801 (15.6)
  Region                                                                     
  West                                                                       1297 (25.3)
  Midwest                                                                    1124 (21.9)
  Northeast                                                                  825 (16.1)
  South                                                                      1868 (36.5)
  Unknown                                                                    8 (0.2)
  Metropolitan statistical area                                              
  Metropolitan                                                               4158 (81.2)
  Nonmetropolitan                                                            588 (11.5)
  Unknown                                                                    376 (7.3)
  Self‐reported health                                                       
  Excellent                                                                  838 (16.4)
  Very good                                                                  2049 (40.0)
  Good                                                                       1699 (33.2)
  Fair                                                                       448 (8.7)
  Poor                                                                       82 (1.6)
  Missing                                                                    6 (0.1)
  Household income                                                           
  \<\$20,000                                                                 512 (10.0)
  \$20,000--\$34,999                                                         696 (13.6)
  \$35,000--\$49,999                                                         619 (12.1)
  \$50,000--\$74,999                                                         904 (17.6)
  \$75,000--\$99,999                                                         681 (13.3)
  \$100,000--\$124,999                                                       577 (11.3)
  \$125,000--\$149,999                                                       312 (6.1)
  \$150,000 or more                                                          576 (11.2)
  Missing                                                                    245 (4.8)
  *Children with autism (age 3 to \<18)*                                     
  Age, years \[mean (*SD*)\]                                                 9.10 (3.92)
  Male                                                                       4096 (80.0)
  Race/ethnicity                                                             
  White/non‐Hispanic                                                         3510 (68.5)
  White/Hispanic                                                             501 (9.8)
  Non‐white/non‐Hispanic                                                     830 (16.2)
  Non‐white/Hispanic                                                         281 (5.5)
  Caregiver‐reported child\'s health                                         
  Excellent                                                                  1694 (33.1)
  Very good                                                                  2174 (42.4)
  Good                                                                       1063 (20.8)
  Fair                                                                       169 (3.3)
  Poor                                                                       13 (0.3)
  Missing                                                                    9 (0.2)
  Autism diagnosis                                                           
  ASD                                                                        3786 (73.9)
  Autism/autistic disorder                                                   553 (10.8)
  Asperger syndrome                                                          455 (8.9)
  PDDNOS                                                                     289 (5.6)
  Unknown/missing                                                            39 (0.8)
  Age at autism diagnosis, years                                             
  0--2                                                                       1337 (26.1)
  3--4                                                                       1999 (39.0)
  5--9                                                                       1418 (27.7)
  \>9                                                                        348 (6.8)
  Missing                                                                    20 (0.4)
  Years since autism diagnosis                                               
  0--1                                                                       1093 (21.3)
  2--3                                                                       1303 (25.4)
  4--5                                                                       883 (17.2)
  6--9                                                                       1130 (22.1)
  ≥10                                                                        697 (13.6)
  Missing                                                                    16 (0.3)
  Insurance                                                                  
  Uninsured/unknown                                                          87 (1.7)
  Only Medicaid                                                              1564 (30.5)
  Only private (via employer)                                                2083 (40.7)
  One type of other coverage                                                 418 (8.2)
  More than one type                                                         970 (18.9)
  Insurance drug coverage                                                    4672 (91.2)
  Prescription drug use                                                      
  Overall                                                                    2683 (52.4)
  Drugs for autism                                                           1718 (33.5)
  Over‐the‐counter drug use                                                  
  Overall                                                                    3106 (60.6)
  Drugs for autism                                                           965 (18.8)
  Medical problems                                                           2348 (45.8)
  Other mental health or psychiatric problems                                2424 (47.3)
  Primary care physician main healthcare provider                            2911 (56.8)
  IQ test results[a](#aur2070-note-0002){ref-type="fn"}                      
  ≤70                                                                        464 (20.1)
  71--99                                                                     564 (24.5)
  ≥100                                                                       789 (34.2)
  Unknown                                                                    488 (21.2)
  Attending school with special education students only                      1109 (21.7)
  Spending more than 60% of classroom time with typically developing peers   2312 (45.1)
                                                                             

ASD: Autism Spectrum Disorder; IQ: intelligence quotient; PDDNOS: pervasive developmental disorder -- not otherwise specified; *SD*: standard deviation.

IQ test results were available for *n* = 2,305 (45.0%).

There were a few demographic differences between children enrolled in special‐education‐only schools (21.7% of the total) and the overall group; notably, mean age was lower, a lower proportion were of White/non‐Hispanic ethnicity, a higher proportion had been diagnosed before 5 years, and had IQ test scores of 70 or below (Supporting Information Table S1).

The mean (*SD*) total AIM score was 220.8 (54.1); possible score range: 82--410, with higher scores indicating higher symptom frequency/impact. Mean (*SD*) \[possible range\] domain scores were: repetitive behavior, 41.1 (13.8) \[16--80\]; communication, 30.6 (11.9) \[12--60\]; atypical behavior, 34.7 (10.1) \[12--60\]; social reciprocity 27.1 (7.4) \[10--50\]; and peer interaction, 22.9 (7.1) \[8--40\].

*Types of Treatments* {#aur2070-sec-0008}
---------------------

As shown in Table [2](#aur2070-tbl-0002){ref-type="table"}, 96.0% of children received at least one type of non‐drug treatment, the most common being SLT (71.4%). A higher proportion of children in metropolitan versus nonmetropolitan areas received behavioral therapy (57.2% vs 46.4%) and SLT (72.3% vs 65.0%). There was a pattern toward lower utilization across urbanization categories from large central metro to noncore for behavioral therapy, SLT, and parent/caregiver training (Supporting Information Table S2). Similar proportions of children covered by Medicaid‐only and private insurance‐only received at least one therapy (96.2% vs 95.4%); although children under Medicaid‐only received occupational therapy more frequently (61.8% vs 55.7%) and "other" therapies less frequently (63.4% vs 69.9%). For most therapies, use decreased from the lowest age group to the highest age group.

###### 

Caregiver‐Reported Types of Non‐Drug Treatments in the Last 12 Months Provided to Children with ASD (*n* = 5,122)

                                                            *N*     Any            Behavioral     Developmental/relationship   SLT            Occupational   Psychological   Other          Parent/caregiver training
  --------------------------------------------------------- ------- -------------- -------------- ---------------------------- -------------- -------------- --------------- -------------- ---------------------------
  Overall                                                   5,122   4,918 (96.0)   2,875 (56.1)   1,348 (26.3)                 3,657 (71.4)   3,078 (60.1)   1,471 (28.7)    3,471 (67.8)   1,515 (29.6)
  Geography                                                                                                                                                                                 
  Metropolitan                                              4,158   4,001 (96.2)   2,378 (57.2)   1,081 (26.0)                 3,005 (72.3)   2,500 (60.1)   1,210 (29.1)    2,828 (68.0)   1,253 (30.1)
  Nonmetropolitan                                           588     551 (93.7)     273 (46.4)     152 (25.9)                   382 (65.0)     334 (56.8)     157 (26.7)      377 (64.1)     142 (24.1)
  Unknown                                                   376     366 (97.3)     224 (59.6)     115 (30.6)                   270 (71.8)     244 (64.9)     104 (27.7)      266 (70.7)     120 (31.9)
  Insurance                                                                                                                                                                                 
  Uninsured/unknown                                         87      75 (86.2)      43 (49.4)      23 (26.4)                    55 (63.2)      44 (50.6)      17 (19.5)       47 (54.0)      16 (18.4)
  Only Medicaid                                             1,564   1,505 (96.2)   860 (55.0)     405 (25.9)                   1,129 (72.2)   967 (61.8)     469 (30.0)      992 (63.4)     401 (25.6)
  Only private (via employer)                               2,083   1,987 (95.4)   1,103 (53.0)   542 (26.0)                   1,429 (68.6)   1,160 (55.7)   607 (29.1)      1,455 (69.9)   620 (29.8)
  One type of other coverage                                418     399 (95.5)     246 (58.9)     112 (26.8)                   268 (64.1)     223 (53.3)     116 (27.8)      270 (64.6)     129 (30.9)
  More than one type                                        970     952 (98.1)     623 (64.2)     266 (27.4)                   776 (80.0)     684 (70.5)     262 (27.0)      707 (72.9)     349 (36.0)
  Child age (years)[a](#aur2070-note-0005){ref-type="fn"}                                                                                                                                   
  3--4                                                      690     679 (98.4)     452 (65.5)     238 (34.5)                   626 (90.7)     525 (76.1)     77 (11.2)       381 (55.2)     253 (36.7)
  5--9                                                      2,183   2,122 (97.2)   1,304 (59.7)   541 (24.8)                   1,770 (81.1)   1,572 (72.0)   463 (21.2)      1,464 (67.1)   695 (31.8)
  10--14                                                    1,641   1,555 (94.8)   836 (50.9)     432 (26.3)                   970 (59.1)     792 (48.3)     672 (41.0)      1,205 (73.4)   415 (25.3)
  15--17                                                    597     551 (92.3)     274 (45.9)     134 (22.4)                   283 (47.4)     179 (30.0)     256 (42.9)      413 (69.2)     148 (24.8)

ASD: Autism Spectrum Disorder; SLT: speech and language therapy.

Numbers represent *n* (%) that were treated in each subgroup.

Missing age, *n* = 11.

Most caregivers reported therapy as ongoing (i.e., not having ended in the 12‐month recall period; ranging from 61.0% for parent/caregiver training to 89.1% for SLT). Approximately 42% reported four or more interventions. Children were most likely to receive SLT and occupational therapy concurrently; followed by parent/caregiver training and behavioral therapy; Supporting Information Table S3. The most common interventions used concurrently were behavioral therapy/SLT/occupational therapy/"other" (7.1%) and SLT/occupational therapy/"other" (5.9%); Supporting Information Table S4. In nonmetropolitan areas, behavioral therapy was not in the three most common concurrently used interventions, and developmental/relationship‐based and parental training not in any of the combinations occurring for \>2% of the children. Overall, 52.0% received at least SLT and occupational therapy, while 79.5% received at least either.

*Intensity of Treatments* {#aur2070-sec-0009}
-------------------------

The median intensity of all treatments was 6.0 hr/week, with behavioral therapy being the most intense (4.0 hr/week, Table [3](#aur2070-tbl-0003){ref-type="table"}). Metropolitan areas reported higher intensity for "any" therapy, behavioral therapy, "other" therapy, and developmental/relationship‐based interventions (also Supporting Information Fig. S4 and Table S5). A difference between Medicaid‐only and private insurance‐only patients was seen only for behavioral therapy (2.0 and 4.0 hr/week, respectively) and "other" (also Supporting Information Fig. S5). Although there was no consistent pattern overall across age groups, the two lowest (3--4 and 5--9 years) had the highest intensity for behavioral therapy.

###### 

Median Intensity[a](#aur2070-note-0007){ref-type="fn"} and Setting of Non‐Drug Treatments in the Last 12 Months Provided to Children with ASD (*n* = 4,918)

                                                             *N* (any)   All    Behavioral   Developmental/relationship   SLT    Occupational   Psychological   Other                                                                           
  --------------------------------------------------------- ----------- ------ ------------ ---------------------------- ------ -------------- --------------- ------- ----- ------ ------ ----- ------ ------ ----- ------ ------ ----- ------ ------
  Overall                                                      4,918     6.0       4.0                  2.16              0.64       2.0            1.35        0.99    1.0   1.74   1.79   1.0   2.93   1.33   1.0   3.27   0.40   2.0   1.21   0.99
  Geography                                                                                                                                                                                                                                     
  Metropolitan                                                 4,001     6.0       4.0                  2.09              0.65       2.0            1.30        1.00    1.0   1.67   1.79   1.0   2.82   1.31   1.0   3.11   0.41   2.0   1.16   0.99
  Nonmetropolitan                                               551      4.5       2.0                  3.21              0.56       1.0            1.67        0.98    1.0   2.46   1.89   1.0   3.73   1.59   1.0   4.72   0.36   1.0   1.60   1.03
  Unknown                                                       366      5.5       3.0                  2.04              0.66       2.0            1.48        0.90    1.0   1.81   1.61   1.0   3.28   1.29   1.0   3.72   0.39   1.0   1.28   0.98
  Insurance                                                                                                                                                                                                                                     
  Uninsured                                                     75       4.5       3.0                  1.65              1.04       1.0            1.27        1.80    1.0   2.09   2.83   1.0   2.53   1.89   1.0   3.00   0.89   1.0   1.28   1.35
  Only Medicaid                                                1,505     5.5       2.0                  2.62              0.66       2.0            1.60        0.97    1.0   2.20   1.70   1.0   3.54   1.30   1.0   3.34   0.43   2.0   1.45   1.03
  Only private (via employer)                                  1,987     5.5       4.0                  1.88              0.68       2.0            1.18        1.05    1.0   1.46   2.04   1.0   2.52   1.40   1.0   3.14   0.41   1.0   1.07   1.01
  One type of other coverage                                    399      6.5       5.5                  2.47              0.46       2.0            1.47        0.90    1.0   1.86   1.41   1.0   3.22   0.99   1.0   5.50   0.34   1.0   1.32   0.89
  More than one type                                            952      8.0       5.0                  2.12              0.62       2.0            1.36        0.91    1.0   1.73   1.60   1.0   2.97   1.38   1.0   2.91   0.36   2.0   1.16   0.92
  Child age (years)[b](#aur2070-note-0008){ref-type="fn"}                                                                                                                                                                                       
  3--4                                                          679      10.0      9.0                  2.39              0.66       3.0            1.82        0.85    1.0   2.61   1.05   1.0   3.83   0.86   1.0   2.36   0.43   1.0   1.75   0.77
  5--9                                                         2,122     7.0       5.0                  2.10              0.65       2.0            1.36        1.02    1.0   1.78   1.71   1.0   3.03   1.34   1.0   2.74   0.49   1.0   1.25   0.95
  10--14                                                       1,555     5.0       2.0                  2.13              0.65       2.0            1.23        1.01    1.0   1.44   2.72   1.0   2.47   1.85   1.0   3.70   0.38   2.0   1.10   1.10
  15--17                                                        551      4.5       2.0                  2.22              0.57       1.0            1.09        1.07    1.0   1.31   3.12   1.0   2.22   1.51   1.0   3.79   0.31   2.0   1.02   1.06

ASD: Autism Spectrum Disorder; Int: intensity (median hours/week), IGR: individual to group sessions ratio, SLT: speech and language therapy; SNR: in school to not in school sessions ratio.

Expressed as median hr/week.

Missing age, *n* = 11.

*Setting of Treatments* {#aur2070-sec-0010}
-----------------------

Non‐drug therapies were more often given in individual rather than group sessions, with psychological interventions and occupational therapy having the highest individual‐to‐group ratios (IGRs: 3.27 and 2.93, respectively, Table [3](#aur2070-tbl-0003){ref-type="table"}). Children in nonmetropolitan areas were more likely to receive individual sessions than those in metropolitan areas; with notable differences seen for behavioral therapy, psychological interventions, occupational therapy, and SLT. Children under Medicaid‐only more often received individual sessions than those under private insurance‐only; with differences seen for occupational therapy, SLT, and behavioral therapy. There was a pattern of individual sessions from lowest in large central metro to highest in noncore (Supporting Information Table S5).

SLT and occupational therapy were more often provided in school (school/not in school ratio \[SNR\]: 1.79 and 1.33, respectively), while behavioral therapy and psychological interventions were more frequently provided outside school (SNR: 0.64 and 0.40, respectively). There were no notable differences in SNR\'s between metropolitan and nonmetropolitan areas. A small difference was seen between the Medicaid‐only and private insurance‐only patients for SLT.

The most common place of care was the home for behavioral interventions (45.0%); public school for developmental/relationship‐based interventions (56.0%), SLT (76.5%), occupational therapy (63.6%), and "other" interventions (57.7%); and private therapist (57.8%) for psychological interventions (Table [4](#aur2070-tbl-0004){ref-type="table"}). Behavioral therapy was most often received in public school in nonmetropolitan areas (44.7%), but at home in metropolitan areas (46.3%).

###### 

Place of Non‐Drug ASD Therapy ‐ by Intervention Type

  Variable                                    *n* (%)                                                             
  ---------------------------------------- -------------- ------------ -------------- -------------- ------------ --------------
  Overall (*N*)                                2,875         1,348         3,657          3,078         1,471         3,471
  Home                                      1,295 (45.0)   403 (29.9)    423 (11.6)     354 (11.5)    182 (12.4)    996 (28.7)
  Public school or pre‐school               1,214 (42.2)   755 (56.0)   2,798 (76.5)   1,958 (63.6)   406 (27.6)   2,004 (57.7)
  Private school or pre‐school               351 (12.2)    152 (11.3)    364 (10.0)     294 (9.6)      93 (6.3)     356 (10.3)
  OP medical/autism clinic                   535 (18.6)    195 (14.5)    407 (11.1)     469 (15.2)    271 (18.4)    435 (12.5)
  Private therapist/clinician office         900 (31.3)    391 (29.0)   1,003 (27.4)    885 (28.8)    850 (57.8)    866 (24.9)
  Daycare or before/after school program      90 (3.1)      29 (2.2)      33 (0.9)       25 (0.8)      6 (0.4)       78 (2.2)
  Camp                                       183 (6.4)      72 (5.3)      43 (1.2)       33 (1.1)      21 (1.4)     452 (13.0)
  Other location                             152 (5.3)      82 (6.1)      43 (1.2)       52 (1.7)      94 (6.4)     341 (9.8)
  Unknown location                            3 (0.1)       4 (0.3)       5 (0.1)        3 (0.1)       3 (0.2)       61 (1.8)

ASD: Autism Spectrum Disorder; D/R: Developmental and/or relationship‐based intervention; OP: Outpatient OT: Occupational Therapy; SLT: Speech and Language Therapy.

Note: Place of non‐drug therapy is not applicable for "Any" intervention; and was not collected for Parent/Caregiver Training intervention.

*Barriers to Treatments* {#aur2070-sec-0011}
------------------------

Overall, 44.8% reported at least one barrier to non‐drug therapy. "Waiting list" (26.4%) was the most common provider‐related barrier (Table [5](#aur2070-tbl-0005){ref-type="table"}), whereas "no coverage" (17.9%) and "cost" (16.7%) were the most common health‐plan‐related barriers (Table [6](#aur2070-tbl-0006){ref-type="table"}). Metropolitan areas reported a higher frequency of "waiting list" than nonmetropolitan areas, but a much lower frequency of "not available in area" (15.1% vs 32.0%).

###### 

Provider Barriers to Non‐Drug Therapy

  Subgroup                        *N*                                 Provider barrier *n* (%)                                                                                                    
  ------------------------------- ----------------------------------- -------------------------- -------------- ------------ ------------ -------------- -------------- ------------ ------------ ------------
  Overall                         5,122                               2,296 (44.8)               881 (17.2)     265 (5.2)    576 (11.2)   1,350 (26.4)   503 (9.8)      512 (10.0)   605 (11.8)   
  6‐level MSA                     Large central metro                 1,248                      572 (45.8)     138 (11.1)   63 (5.0)     169 (13.5)     369 (29.6)     106 (8.5)    134 (10.7)   134 (10.7)
  Large fringe metro              1,527                               682 (44.7)                 236 (15.5)     75 (4.9)     183 (12.0)   408 (26.7)     149 (9.8)      166 (10.9)   179 (11.7)   
  Medium metro                    938                                 401 (42.8)                 151 (16.1)     59 (6.3)     87 (9.3)     232 (24.7)     92 (9.8)       91 (9.7)     116 (12.4)   
  Small metro                     445                                 202 (45.4)                 104 (23.4)     18 (4.0)     46 (10.3)    116 (26.1)     46 (10.3)      43 (9.7)     59 (13.3)    
  Nonmetropolitan: micropolitan   369                                 157 (42.5)                 102 (27.6)     17 (4.6)     31 (8.4)     77 (20.9)      47 (12.7)      30 (8.1)     44 (11.9)    
  Nonmetropolitan: noncore        219                                 105 (47.9)                 86 (39.3)      19 (8.7)     22 (10.0)    44 (20.1)      27 (12.3)      17 (7.8)     31 (14.2)    
  Unknown                         376                                 177 (47.1)                 64 (17.0)      14 (3.7)     38 (10.1)    104 (27.7)     36 (9.6)       31 (8.2)     42 (11.2)    
  2‐level MSA                     Metropolitan                        4,158                      1,857 (44.7)   629 (15.1)   215 (5.2)    485 (11.7)     1,125 (27.1)   393 (9.5)    434 (10.4)   488 (11.7)
  Nonmetropolitan                 588                                 262 (44.6)                 188 (32.0)     36 (6.1)     53 (9.0)     121 (20.6)     74 (12.6)      47 (8.0)     75 (12.8)    
  Unknown                         376                                 177 (47.1)                 64 (17.0)      14 (3.7)     38 (10.1)    104 (27.7)     36 (9.6)       31 (8.2)     42 (11.2)    
  Healthcare coverage             Uninsured (including do not know)   87                         44 (50.6)      17 (19.5)    5 (5.7)      7 (8.0)        22 (25.3)      9 (10.3)     6 (6.9)      13 (14.9)
  Medicaid only                   1,564                               713 (45.6)                 315 (20.1)     122 (7.8)    158 (10.1)   431 (27.6)     190 (12.1)     175 (11.2)   217 (13.9)   
  Private (via employer) only     2,083                               873 (41.9)                 290 (13.9)     71 (3.4)     235 (11.3)   488 (23.4)     162 (7.8)      166 (8.0)    197 (9.5)    
  One type of other coverage      418                                 211 (50.5)                 81 (19.4)      17 (4.1)     46 (11.0)    121 (28.9)     50 (12.0)      43 (10.3)    54 (12.9)    
  More than one type              970                                 455 (46.9)                 178 (18.4)     50 (5.2)     130 (13.4)   288 (29.7)     92 (9.5)       122 (12.6)   124 (12.8)   

MSA: Metropolitan Statistical Area.

###### 

Health Plan and Other Barriers to Non‐Drug Therapy

  Subgroup                        *N*                                  Health plan and other barriers *n* (%)                                                                                  
  ------------------------------- ----------------------------------- ---------------------------------------- -------------- ------------ ------------ ------------ ------------ ------------ -----------
  Overall                         5,122                                             2,296 (44.8)               854 (16.7)     64 (1.2)     918 (17.9)   179 (3.5)    692 (13.5)   315 (6.1)    
  Six‐level MSA                   Large central metro                                  1,248                   572 (45.8)     242 (19.4)   19 (1.5)     245 (19.6)   54 (4.3)     196 (15.7)   75 (6.0)
  Large fringe metro              1,527                                              682 (44.7)                288 (18.9)     22 (1.4)     297 (19.4)   45 (2.9)     239 (15.7)   98 (6.4)     
  Medium metro                    938                                                401 (42.8)                128 (13.6)     9 (1.0)      157 (16.7)   30 (3.2)     107 (11.4)   52 (5.5)     
  Small metro                     445                                                202 (45.4)                68 (15.3)      2 (0.4)      68 (15.3)    18 (4.0)     52 (11.7)    27 (6.1)     
  Nonmetropolitan: micropolitan   369                                                157 (42.5)                51 (13.8)      5 (1.4)      50 (13.6)    14 (3.8)     35 (9.5)     24 (6.5)     
  Nonmetropolitan: noncore        219                                                105 (47.9)                21 (9.6)       1 (0.5)      31 (14.2)    8 (3.7)      17 (7.8)     15 (6.8)     
  Unknown                         376                                                177 (47.1)                56 (14.9)      6 (1.6)      70 (18.6)    10 (2.7)     46 (12.2)    24 (6.4)     
  Two‐level MSA                   Metropolitan                                         4,158                   1,857 (44.7)   726 (17.5)   52 (1.3)     767 (18.4)   147 (3.5)    594 (14.3)   252 (6.1)
  Nonmetropolitan                 588                                                262 (44.6)                72 (12.2)      6 (1.0)      81 (13.8)    22 (3.7)     52 (8.8)     39 (6.6)     
  Unknown                         376                                                177 (47.1)                56 (14.9)      6 (1.6)      70 (18.6)    10 (2.7)     46 (12.2)    24 (6.4)     
  Healthcare coverage             Uninsured (including do not know)                      87                    44 (50.6)      24 (27.6)    20 (23.0)    18 (20.7)    3 (3.4)      14 (16.1)    4 (4.6)
  Medicaid only                   1,564                                              713 (45.6)                195 (12.5)     13 (0.8)     249 (15.9)   76 (4.9)     217 (13.9)   103 (6.6)    
  Private (via employer) only     2,083                                              873 (41.9)                391 (18.8)     12 (0.6)     375 (18.0)   35 (1.7)     251 (12.0)   115 (5.5)    
  One type of other coverage      418                                                211 (50.5)                56 (13.4)      7 (1.7)      70 (16.7)    32 (7.7)     48 (11.5)    30 (7.2)     
  More than one type              970                                                455 (46.9)                188 (19.4)     12 (1.2)     206 (21.2)   33 (3.4)     162 (16.7)   63 (6.5)     

MSA: Metropolitan Statistical Area.

*Caregiver\'s Role and Perception* {#aur2070-sec-0012}
----------------------------------

Table [7](#aur2070-tbl-0007){ref-type="table"} lists the non‐drug therapies in the "other" category. The most frequent therapies were social skills training (37.0%) and academic support (28.3%). The main care coordinator was the caregiver (81.9%). Three quarters reported that they were satisfied with the current level of care, and 58.2% reported that their child benefited "much" or "very much" from care.

###### 

Non‐Drug ASD Therapies in the "Other" Category (*n* = 3,471)

  Type                                                                               *n*     \%
  -------------------------------------------------------------------------------- ------- -------
  Social skills training                                                            1,894   36.98
  Academic support (for example reading, writing, and math tutor)                   1,450   28.31
  Sensory integration                                                                792    15.46
  Physical therapy                                                                   739    14.43
  Recreational[a](#aur2070-note-0014){ref-type="fn"}                                 715    13.96
  Biomedical[b](#aur2070-note-0015){ref-type="fn"}                                   431    8.41
  Animal‐assisted activities and therapies[c](#aur2070-note-0016){ref-type="fn"}     395    7.71
  Other therapy not previously mentioned                                             395    7.71
  Other therapy -- but do not know which                                             234    4.57
  Fast Forward, APE                                                                  206    4.02
  Structured teaching (TEACCH)                                                       177    3.46
  SCERTS                                                                             152    2.97
  AIT                                                                                78     1.52
  The Built Environment                                                               2     0.04

AIT: auditory integration training/therapy; APE: Adaptive physical education; ASD: Autism Spectrum Disorder; SCERTS: Social Communication/Emotional Regulation/Transactional Support; TEACCH: Training and Education of Autistic and Related Communication Handicapped Children.

For example, specialized summer camp.

For example, biofeedback, special diets, vitamins.

For example, therapies including dogs, horses, dolphins.

*Associations between Treatments and Geography/Insurance* {#aur2070-sec-0013}
---------------------------------------------------------

As shown in Table [8](#aur2070-tbl-0008){ref-type="table"}, the odds of receiving "any" treatment, behavioral therapy and SLT were significantly greater in metropolitan areas than in nonmetropolitan areas (odds ratio \[OR\] 1.71, 1.54, and 1.41, respectively). No consistently (i.e., significant in both, the PS‐adjusted and double‐adjusted analyses) significant associations were seen between type of insurance (Medicaid‐only vs private insurance‐only) and type of treatment received.

###### 

Association of Caregiver‐Reported Type and Intensity of Non‐Drug Therapy with Geography and Insurance

  Non‐drug therapy type                                   Geography (metropolitan vs nonmetropolitan)   Insurance[a](#aur2070-note-0019){ref-type="fn"}, [b](#aur2070-note-0020){ref-type="fn"}  
  ------------------------------------------------------ --------------------------------------------- ----------------------------------------------------------------------------------------- ------------------
  *Association with type of therapy: OR (95% CI)*                                                                                                                                                
  Any                                                                  1.71 (1.17,2.45)                                                    0.63 (0.34,1.17)                                       0.58 (0.32,1.06)
  Behavioral                                                           1.54 (1.30,1.83)                                                    1.12 (0.78,1.62)                                       1.07 (0.78,1.47)
  Developmental/ relationship                                          1.01 (0.83,1.23)                                                    0.99 (0.65,1.52)                                       1.04 (0.73,1.50)
  SLT                                                                  1.41 (1.17,1.69)                                                    0.67 (0.44,1.03)                                       0.66 (0.45,0.97)
  Occupational                                                         1.15 (0.96,1.36)                                                    0.80 (0.54,1.19)                                       0.77 (0.55,1.09)
  Psychological                                                        1.13 (0.93,1.37)                                                    0.77 (0.55,1.09)                                       0.69 (0.49,0.97)
  Other                                                                1.19 (0.99,1.42)                                                    0.86 (0.58,1.26)                                       0.86 (0.62,1.20)
  *Association with intensity of therapy: RR (95% CI)*                                                                                                                                           
  Any                                                                  1.35 (1.23,1.48)                                                    0.90 (0.75,1.07)                                       0.84 (0.72,0.97)
  Behavioral                                                           1.71 (1.45,2.01)                                                    1.02 (0.81,1.27)                                       0.98 (0.78,1.24)
  Developmental/relationship                                           1.23 (0.95,1.57)                                                    1.37 (0.93,2.01)                                       0.99 (0.70,1.39)
  SLT                                                                  1.18 (1.06,1.31)                                                    0.90 (0.70,1.17)                                       0.88 (0.72,1.07)
  Occupational                                                         1.04 (0.93,1.17)                                                    0.83 (0.64,1.08)                                       0.83 (0.66,1.05)
  Psychological                                                        1.46 (1.19,1.79)                                                    0.89 (0.60,1.32)                                       0.81 (0.56,1.17)
  Other                                                                1.19 (1.04,1.35)                                                    0.66 (0.54,0.81)                                       0.65 (0.54,0.80)

CI: Confidence interval; OR: Odds Ratio; PS: propensity score; RR: Rate ratio; SLT: Speech and language therapy.

Variables for adjustment: AIM domain scores (continuous), child race/ethnicity (White/Hispanic, White/Non‐Hispanic, Non‐White/Hispanic, Non‐White/Non‐Hispanic), child other medical problems (yes/no), child other mental health or psychiatric problems (yes/no), geography (nonmetropolitan/ metropolitan), household income (four strata, ≥\$20,000 to ≤\$99,999), marital status (married/living with partner yes/no), mother employment (work full‐time/part time yes/no), US state (excluded states with *n* \< 3 for Medicaid and private employer insurance).

Models for insurance were adjusted for below variables using propensity score inverse probability weighting (adjusted and double‐adjusted: see Methods section and Supplementary Appendix).

See Supporting Information Table S6 for trimmed results.

The intensity of "any" treatment was significantly greater in metropolitan areas than in nonmetropolitan areas (relative risk, 1.35), based on the intensities of behavioral therapy, SLT, psychological and "other" interventions that were all significantly greater in metropolitan areas. The RRs for the intensity of any of the treatment options did not indicate a consistently significant difference between the two types of healthcare coverage, except for "other," where the rates were lower for those with private insurance provided by employer. For results on the six‐level MSA and other additional analyses, refer to the Supporting Information Tables S6--S9.

Discussion {#aur2070-sec-0014}
==========

This study investigated the caregiver‐reported pattern of non‐drug therapy and the variability of care by geographic region and type of healthcare coverage, in children with ASD.

The cohort was largely representative of children with ASD in the United States. U.S. population weighted survey data, from the 2016 National Survey of Children\'s Health \[Data Resource Center for Child & Adolescent Health, [2018](#aur2070-bib-0005){ref-type="ref"}\], reported a similar male‐to‐female ratio (around 80% male), use of medications for autism (around 1/3), age at diagnosis (around 1/3 beyond age 5), and insurance coverage (around 98% with coverage). The sample of the 2016 survey included close to 70% White/non‐Hispanics, as in our study, while the population estimate was around 53%, indicating over‐representation of this group among the survey respondents.

Salomone et al. \[[2016](#aur2070-bib-0016){ref-type="ref"}\] who grouped therapies similarly, reported that 91% of respondents from 18 European countries used at least one non‐drug therapy (vs 96% in our study). Behavioral therapy, SLT, and occupational therapy were reported at 32%, 64%, and 35%, although there was wide variation across countries. Our study reported higher rates \[66% and 60%, 91% and 81%, 76% and 72% for these therapies, for the age groups 3--4 and 5--9 years, respectively, corresponding best to the age range investigated by Salomone et al., [2016](#aur2070-bib-0016){ref-type="ref"}\]. Most children in our cohort received more than one non‐drug therapy. Approximately one‐quarter used three therapies concurrently and two‐thirds used three or more in the past 12 months; the most common combination being behavioral therapy/SLT/occupational therapy/"other" (7.1%). It is difficult to compare these rates with other studies as they either did not use similar groupings of non‐drug treatments, included medications and other modalities (e.g., vitamin supplements) in their count of combinations, or did not report on combinations at all. Guidelines recommended intensity of treatment, that is, 25 hr/week for children \[Maglione et al., [2012](#aur2070-bib-0011){ref-type="ref"}\], was not achieved in our study. Even the most intense treatments have not reached this level (children aged 3--4, four or more different interventions, mean intensity 19.7 hr/week).

SLT was the most frequently used therapy in our study and was predominantly provided at public schools. That SLT was the most frequent therapy agrees with previous findings in the United States \[Becerra et al., [2017](#aur2070-bib-0002){ref-type="ref"}\] (from a 2012 survey of four Kaiser Permanente regions) and in Europe \[Salomone et al., [2016](#aur2070-bib-0016){ref-type="ref"}\]. Since communication deficits are a core symptom of ASD, the high rate of SLT is not surprising.

We classified geography based on state and county, defining six levels of urbanization from most urban/highest density to most rural/lowest density \[Ingram & Franco, [2014](#aur2070-bib-0008){ref-type="ref"}\]. The difference in frequency of "any" treatment between metropolitan and nonmetropolitan areas (96.2% vs 93.7%, OR 1.71 \[95% CI 1.17, 2.45\]), although significant, was less pronounced than might have been expected \[Kelleher & Gardner, [2017](#aur2070-bib-0010){ref-type="ref"}\]. This may be because the most frequently used therapies (SLT and occupational therapy) are mostly provided at public school, and are thus not dependent on infrastructure such as specialists\' offices. The intensity of "any" treatment was also significantly greater in metropolitan areas than in nonmetropolitan areas; mostly driven by significant differences in the intensity of behavioral therapy, SLT, psychological, and "other" interventions. Specifically, behavioral therapy was less often used in nonmetropolitan settings, and, where used, was much less intense. Given that public school was reported as the most frequent setting for this therapy in nonmetropolitan areas, its use as a platform for care delivery probably warrants further consideration. Kelleher and Gardner \[[2017](#aur2070-bib-0010){ref-type="ref"}\] have additionally suggested telehealth programs to provide better access to behavioral therapy in remote areas. The level of urbanization has an influence on the number of children diagnosed with ASD \[Antezana, Scarpa, Valdespino, Albright, & Richey, [2017](#aur2070-bib-0001){ref-type="ref"}\], also called "treated prevalence" \[Mandell et al., [2016](#aur2070-bib-0012){ref-type="ref"}\]. Hence, the true difference in unmet need between metropolitan and nonmetropolitan areas is likely underestimated in our study.

Historically, large differences have been reported for ASD‐related services between children covered under Medicaid versus those under private insurance, such that Medicaid spending was much higher \[Wang et al., [2013](#aur2070-bib-0020){ref-type="ref"}; Zhang & Baranek, [2016](#aur2070-bib-0021){ref-type="ref"}\]. We were able to investigate the association between frequency/intensity and type of healthcare coverage in two mutually exclusive insurance groups, namely Medicaid‐only and private employer‐based‐only. We made these groups as comparable as possible by focusing on a subgroup of children with similar characteristics and further adjusting for important confounders. No significant differences in the frequency or intensity of treatment was observed, with the exception that intensity for "other" interventions was lower in privately insured children. However, given that the sample size for this analysis was substantially smaller than for the analysis of association with geography, the results may also reflect limited statistical power, as point estimates mostly directionally favored Medicaid, except for behavioral and developmental/relationship‐based therapies.

Our study has some limitations. The use of the SPARK cohort might have introduced selection bias toward caregivers with higher motivation and higher education. This is likely to have underestimated the difference between nonmetropolitan and metropolitan areas, given the known associations between area of residence and educational level and likelihood of seeking treatment \[Payakachat et al., [2018](#aur2070-bib-0015){ref-type="ref"}\]. The possibility of recall bias cannot be ruled out as the study relied on caregiver‐reported information over the previous year. However, as most of the treatments were still ongoing, this seems to be less of a concern. Our grouping of treatment options into categories may not be universally acceptable, although a very similar grouping has been used before \[Salomone et al., [2016](#aur2070-bib-0016){ref-type="ref"}\], and caregivers may not have been able to clearly identify and distinguish the different treatment options. We also did not collect in the "Other" category further details for the response option "Other therapy not previously mentioned," which may include those considered complementary health approaches. Finally, as this was a cross‐sectional study, it is not possible to conclude any causal relationships, particularly between geographic region and any type of healthcare coverage, although it is implied that the pattern of care is determined by geography of residence and type of coverage.

Strengths of this study lie in the recency of the data presented (2016 and 2017), and its collection from a large sample not linked to a specific provider or network of centers, and no reliance on claims data. Since most respondents reported themselves as the main care coordinator, the data are likely to be complete. The design of the survey also allowed us to capture important details including the setting of care. Finally, these data will be made available via SPARK, and will be linkable to other data collected from the same cohort.

While this study provides unprecedented detail on current non‐drug therapy in ASD for children in the United States, future research should investigate the effectiveness of those treatments in routine practice.
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###### 

Click here for additional data file.
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